As the year draws to a close, Wall Street is set to crown Eli Lilly (NYSE:LLY) among the best in Big Pharma, while Novo ...

The industry’s intellectual property manipulations are stealing from your pockets—and limiting the benefits of the Biden ...

To navigate this increasingly complex environment in 2025, pharma manufacturers must fundamentally rethink their models and ...

The biotech company said that it would also implement cost-cutting measures, including layoffs. Chief Executive Ahmed Hamdy and Chief Financial Officer Alexander Seelenberger have both stepped down in ...

Mankind Pharma has entered into a partnership with Innovent Biologics for exclusively licensing and commercialising ...

Japan effect funnels billions into North Carolina Pharma giant eyes Eastern NC for 420-job, billion-dollar plant Related: ...

The words “precision” and “precision healthcare” came up more than a handful of times in MM+M’s survey results. According to Ian Liu, global market leader for healthcare at Alorica, precision ...

Look no further than our top two stories of the year, and you’ll see that the GLP-1 craze and Big Pharma layoffs took center ...

The Indian pharmaceutical industry is poised for significant transformation by 2025, driven by technological advancements ...

Swiss private equity firm Partners Group Holding AG is looking to rearrange its India portfolio that has quadrupled to more ...